ABNORMAL B-LYMPHOCYTE DEVELOPMENT, ACTIVATION, AND DIFFERENTIATION IN MICE THAT LACK OR OVEREXPRESS THE CD19 SIGNAL-TRANSDUCTION MOLECULE

被引:485
|
作者
ENGEL, P [1 ]
ZHOU, LJ [1 ]
ORD, DC [1 ]
SATO, S [1 ]
KOLLER, B [1 ]
TEDDER, TF [1 ]
机构
[1] UNIV N CAROLINA, DEPT MED, CHAPEL HILL, NC 27510 USA
关键词
D O I
10.1016/1074-7613(95)90157-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD19-deficient mice were generated to examine the role of CD19 in B cell growth regulation in vivo. Deletion of CD19 had no deleterious effects on the generation of B cells in the bone marrow, but there was a significant reduction in the number of B cells in peripheral lymphoid tissues. B cells from CD19-deficient mice exhibited markedly decreased proliferative responses to mitogens, and serum immunoglobulin levels were also significantly decreased. In contrast, mice that overexpressed CD19 had significant defects in early B cell development in the bone marrow, augmented mitogenic responses, and increased serum immunoglobulin levels. These experiments indicate that CD19 functions to define signaling thresholds for cell surface receptors that regulate B lymphocyte selection, activation, and differentiation.
引用
收藏
页码:39 / 50
页数:12
相关论文
共 50 条
  • [31] X-LINKED B-LYMPHOCYTE DEFECT IN CBA-N MICE .3. ABNORMAL DEVELOPMENT OF B-LYMPHOCYTE POPULATIONS DEFINED BY THEIR DENSITY OF SURFACE-IMMUNOGLOBULIN
    SCHER, I
    SHARROW, SO
    PAUL, WE
    JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 144 (02): : 507 - 518
  • [32] Translocation of CD45 to lipid raft signalling domains and abnormal relocation during B-lymphocyte activation in SLE
    Flores-Borja, F
    Kabouridis, PS
    Jury, E
    Isenberg, D
    Mageed, RA
    RHEUMATOLOGY, 2005, 44 : I17 - I17
  • [33] The CD19 molecule is crucial for MID-dependent activation of tonsillar B cells from children
    Hadzic, R
    Forsgren, A
    Cardell, LO
    Riesbeck, K
    Wingren, AG
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2005, 61 (02) : 165 - 172
  • [34] CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity
    Sato, S
    Ono, N
    Steeber, DA
    Pisetsky, DS
    Tedder, TF
    JOURNAL OF IMMUNOLOGY, 1996, 157 (10): : 4371 - 4378
  • [35] Gamma-glutamyl transpeptidase (GGT), a regulator of intracellular redox potential, is physically associated with the B lymphocyte CD21/CD19/TM4 signal transduction complex.
    Holers, VM
    Karp, DR
    Guthridge, JM
    Nichols, TC
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1213 - 1213
  • [36] Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death
    Hicks, GG
    Singh, N
    Nashabi, A
    Mai, S
    Bozek, G
    Klewes, L
    Arapovic, D
    White, EK
    Koury, MJ
    Oltz, EM
    Van Kaer, L
    Ruley, HE
    NATURE GENETICS, 2000, 24 (02) : 175 - 179
  • [37] Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death
    Geoffrey G. Hicks
    Nagendra Singh
    Abudi Nashabi
    Sabine Mai
    Gracjan Bozek
    Ludger Klewes
    Djula Arapovic
    Erica K. White
    Mark J. Koury
    Eugene M. Oltz
    Luc Van Kaer
    H. E. Ruley
    Nature Genetics, 2000, 24 : 175 - 179
  • [38] IDENTIFICATION OF THE INTRACYTOPLASMIC REGION ESSENTIAL FOR SIGNAL TRANSDUCTION THROUGH A B-CELL ACTIVATION MOLECULE, CD40
    INUI, S
    KAISHO, T
    KIKUTANI, H
    STAMENKOVIC, I
    SEED, B
    CLARK, EA
    KISHIMOTO, T
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (08) : 1747 - 1753
  • [39] ABNORMAL SIGNAL-TRANSDUCTION THROUGH CD4 LEADS TO ALTERED TYROSINE PHOSPHORYLATION IN T-CELLS DERIVED FROM LUPUS-PRONE MICE
    MADAIO, MP
    DUAN, JM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 343 - 343
  • [40] CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: Altered signaling in CD22-deficient mice
    Sato, S
    Miller, AS
    Inaoki, M
    Bock, CB
    Jansen, PJ
    Tang, MLK
    Tedder, TF
    IMMUNITY, 1996, 5 (06) : 551 - 562